TMC Pharma Services is a global pharmaceutical developer.

Investment type
  • Management buyout


Milestones reached

In 2023, TMC strengthened its team with four seasoned and talented industry executives  as it continues to grow internationally. Successfully attracting these to TMC is another milestone development in TMC’s growth as it has grown headcount by >20% since LDC’s investment.

Since partnering with LDC, TMC has also started to increase its international focus with 80% of customers now based in the US.

Together Caring for Rare Disease

TMC Pharma Services was part of a news-style programme produced by ITN Business to mark Rare Disease Day on 28 February. The programme, ‘Together Caring for Rare Disease’, has been produced in partnership with Genetic Alliance UK and covers the complexity and life-limiting impact of rare diseases, along with how technology, science, treatment and management can make a difference, and includes interviews with the TMC Pharma team about their work.

Quote mark

LDC’s relationship-focused approach, coupled with their sector knowledge and experience of supporting international growth strategies made them the perfect choice of partner to support TMC on the journey ahead.”

Julie Matthews, CEO
TMC Pharma Services